INFUSION THERAPY IN PERI-OPERATIVE PERIOD
https://doi.org/10.21292/2078-5658-2016-13-5-66-73
Abstract
Goal: to familiarize Russian anesthesiologists with the most recent data of the evidence-based medicine about peri-operative infusion therapy. The right choice of the infusion therapy strategy and tactics is a mandatory component of the successful management of the peri-operative period. The most significant changes have recently occurred specifically in this field. First the concept of restrictive tactics of infusion therapy emerged and won its popularity very fast. Then some reasonable doubts appeared about feasibility and safety of using HES solutions. Both affect basic principles of infusion therapy and the recent changes are to be considered from the position of the evidence-based medicine. British and German experts attended these issues and published the relevant guidelines in 2011 and 2016. Comparison and analysis of the implementation opportunities in Russia and recommendations make the subject of this publication. Conclusion: It is necessary to implement the international recommendations for peri-operative infusion therapy with adjustment to relevant Russian regulations in the anesthesiology and intensive care departments.
About the Author
V. V. Likhvantsev
M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow
Russian Federation
Doctor of Medical Sciences, Professor, Head of Intensive Care Department
Russian Federation
Doctor of Medical Sciences, Professor, Head of Intensive Care Department
References
1. Boniatti M.M., Cardoso P.R., Castilho R.K. et al. Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J. Crit. Care, 2011, vol. 26, pp. 175-179.
2. Garzotto F., Ostermann M., Martín-Langerwerf D. et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit. Care, 2016, vol. 20, pp. 196-210.
3. Hydroxyethyl-starch solutions (HES) no longer to be used in patients with sepsis or burn injuries or in critically ill patients. EMA, 2013, 809470.
4. Kristensen S.D., Knuuti J., Saraste A. et al. 2014 ESC/ESA Guidelines on non-cardiac surgery:cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Europ. Heart Journal, 2014, vol. 35, pp. 2383-2431.
5. Lakhal K., Ehrmann S., Benzekri-Lefevre D. et al. Brachial cuff measurements of blood pressure during passive leg raising for fluid responsiveness prediction. Ann. Fr. Anesth. Reanim., 2012, vol. 31, pp. 67-72.
6. Latta T. Malignant cholera. Documents communicated by the Central Board of Health, London, relative to the treatment of cholera by copious injection of aqueous and saline fluids into the veins. Lancet, 1832, pp. 274-277.
7. Lobo D.N., Macafee D.A., Allison S.P. How perioperative fluid balance influences postoperative outcomes. Best Pract. Res. Clin. Anaesthesiol., 2006, vol. 20, pp. 439-455.
8. Marx G., Schindler A.W., Mosch C. et al. Intravascular volume therapy in adults. Eur. J. Anaesthesiol., 2016, vol. 33, pp. 1-34.
9. McKendry M., McGloin H., Saberi D. et al. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiacsurgery. BMJ, 2004, vol. 329, pp. 258-269.
10. Monnet X., Julien F., Ait-Hamou N. et al. Lactate and venoarterial carbon dioxide difference/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders. Crit. Care Med., 2013, vol. 41, pp. 1412-1420.
11. Monnet X., Teboul J.L. Passive leg raising: five rules, not a drop of fluid! Crit. Care, 2015, vol. 19, pp. 18-23.
12. Moore F.D. Metabolic Care of the Surgical Patient. Philadelphia: W. B. Saunders. 1959.
13. Mortelmans Y., Vermaut G., Verbruggen A. et al. Effects of 6% Hydroxyethyl Starch and 3% Modified Fluid Gelatin on Intravascular Volume and Coagulation During Intraoperative Hemodilution. Anesth. Analg., 1995, vol. 81, pp. 1235-1242.
14. Pearse R.M., Belsey J., Cole J. et al. Effect of dopexamine infusion on mortality following major surgery: Individual patient data meta-regression analysis of published clinical trials. Crit. Care Med., 2008, vol. 36, pp. 1323-1329.
15. Pearse R.M., Dawson D., Fawcett J. et al. The incidence of myocardial injury following post-operative Goal Directed Therapy. BMC Cardiovasc. Disord., 2007, vol. 7, pp. 10-18.
16. Polonen P., Ruokonen E., Hippelainen M. et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth. Analg., 2000, vol. 90, pp. 1052-1059.
17. Powell-Tuck J., Gosling P., Lobo D.N. et al.1 British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients. GIFTASUP. 2011, – http://www.bapen.org.uk/pdfs/bapen_pubs/giftasup.pdf
18. Roquilly A., Loutrel O., Cinotti R. et al. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study. Crit. Care, 2013, vol. 17, pp. 77-85.
19. Saugel B., Kirsche S., Hapfelmeier A. et al. Prediction of fluid responsiveness in patients admitted to the medical intensive care unit. J. Crit. Care, 2013, vol. 28, pp. 537-541.
20. Saugel B., Ringmaier S., Holzapfel K. et al. Physical examination, central venous pressure, and chest radiography for the prediction of transpulmonary thermodilution-derived hemodynamic parameters in critically ill patients: a prospective trial. J. Crit. Care, 2011, vol. 26, pp. 402-410.
21. Shaw A.D., Bagshaw S.M., Goldstein S.L. et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to plasma-lyte. Ann. Surg., 2012, vol. 255, pp. 821-829.
22. Shin Y.H., Ko J.S., Gwak M.S. et al. Utility of uncalibrated femoral stroke volume variation as a predictor of fluid responsiveness during the anhepatic phase of liver transplantation. Liver Transplant., 2011, vol. 17, pp. 53-59.
23. Shoemaker W.C., Appel P.L., Kram H.B. et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest, 1988, vol. 94, pp. 1176-1186.
24. Stoneham M.D., Hill E.L. Variability in post-operative fluid and electrolyte prescription. Br. J. Clin. Pract., 1997, vol. 51, pp. 82–84.
25. Wang N., Jiang L., Zhu B. et al. Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study. Crit. Care, 2015, vol. 19, pp. 371–384.
26. Wilkes N.J., Woolf R., Mutch M. et al. The effects of balanced versus salinebased hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth. Analg., 2001, vol. 93, pp. 811-816.
27. Yunos N.M., Bellomo R., Hegarty C. et al. Association between a chlorideliberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA, 2012, vol. 308, pp. 1566-1572.
28. Zikria B.A., Bascom J.U. Mechanisms of multiple organ failure. In: Zikria BA, Oz MC, Carlson RW, eds. Reperfusion injuries and clinical capillary leak syndrome. Armonk, NY: Futura, 1994.
Review
For citations:
Likhvantsev V.V. INFUSION THERAPY IN PERI-OPERATIVE PERIOD. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2016;13(5):66-73. (In Russ.) https://doi.org/10.21292/2078-5658-2016-13-5-66-73
Email this article 